6 & 7 February, 2024  |  Free Online Conference
Welcome to the Antimicrobial Chemotherapy Conference. Explore the scientific programme and register your attendance below.
This virtual conference is jointly organised by GARDP and BSAC. For ACC2024, the collaborating organisations are the European Clinical Research Alliance on Infectious Diseases (Ecraid) and the Netherlands Antibiotic Development Platform (NADP).

Programme

Details of the conference sessions and presentations are below.

Select to see different time zones. Default is GMT. Time Zone Converter – Time Difference Calculator


1300
1400
1830
0800
Introductory remarks
Dr Christopher Longshaw, Shionogi BV & BSAC Honorary Treasurer - View Bio
SESSION ONE: KEYNOTE PRESENTATION
1305
1405
1835
0805
Presentation title to be confirmed
Professor Gunnar Kahlmeter, Professor of Clinical bacteriology Clinical microbiology for Blekinge & Kronoberg counties & Head of the EUCAST Development Laboratory & EUCAST Technical Data Coordinator and Webmaster
1325
1425
1855
0825
Q&A
1335
1435
1905
0835
Break
SESSION TWO: Drug discovery: new targets and new chemistry
Chair: Professor Nathaniel Martin, Leiden University - View Bio
1345
1445
1915
0845
Discovery of semi-synthetic antibiotics and adjuvants
Professor Jayanta Haldar, Jawaharlal Nehru Centre for Advanced Research (JNCASR), Bangalore, India
1400
1500
1930
0900
Genome mining pipelines and tools to guide the discovery of new antibiotics
Professor Nadine Ziemert, German Centre for Infection Research (DZIF) - View Bio
1415
1515
1945
0915
AI to discover new antibiotics for Gram-negative bacteria
Dr Jon Stokes, McMaster University
14:30
1530
2000
0930
Q&A
1440
1540
2010
0940
Break
SESSION THREE: Preclinical antimicrobial development
Chair: Dr François Franceschi, GARDP - View Bio
1450
1550
2020
0950
Bugworks: New gyrase inhibitors
1505
1605
2035
1005
Phico Therapeutics: Engineered phages
1520
1620
2050
1020
GangaGen (large Molecules)
1535
1635
2105
1035
Q&A
1545
1645
2115
1045
Break
SESSION FOUR: PANEL DISCUSSION: How useful/successful are the WHO Priority Pathogen lists at identifying future targets for Antimicrobial Discovery Programmes?
1555
1655
2125
1055
Panel discussion
1650
1750
2220
1150
Q&A
1700
1800
2230
1200
Closing remarks
Dr Alison Luckey, GARDP - View Bio
1300
1400
1830
0800
Introductory remarks
Dr Alison Luckey, GARDP - View Bio
SESSION FIVE: Clinical development and use of new agents
1305
1405
1835
0805
Navigating the regulatory process for "niche" antibiotics - Lessons learned from a Pathogen-focused clinical development pathway
Dr Matthew Ronsheim, Innoviva Specialty Therapeutics
1320
1420
1850
0820
Use of meta data analysis in antibiotic clinical development
Professor Philippe Guérin, University of Oxford - View Bio
1335
1435
1905
0835
Can we include assessment of risk of resistance in clinical trials for novel antibiotics? 
Marco Cavaleri, European Medicines Agency
1350
1450
1920
0850
Q&A
1400
1500
1930
0900
Break
SESSION SIX: ORAL POSTER PRESENTATIONS
1410
1510
1940
0910
tbc
1415
1515
1945
0915
tbc
1420
1520
1950
0920
tbc
1425
1525
1955
0925
tbc
1430
1530
2000
0930
tbc
1435
1535
2005
0935
Q&A
1445
1545
2015
0945
Break
SESSION SEVEN: Access/stewardship/policy/recent developments
Chair: Professor Evelina Tacconelli, Verona University Hospital, Italy & DZIF Clinical Research Unit, University of Tübingen, Germany - View Bio
1455
1555
2025
0955
Implementation of AMS strategy across a diverse nation(s)
Dr Abdul Ghafur, Chennai Declaration on AMR, Apollo Adjunct Professor & Consultant in Infectious Diseases Apollo Cancer Institute
1510
1610
2040
1010
Monitoring resistance and consumption of new antibiotics: who, how, when 
Dominique Monnet, ECDC
1525
1625
2055
1025
Antimicrobial shortages/supply chain analysis
Dr Esmita Charani, University of Cape Town - View Bio
1540
1640
2110
1040
Q&A
1550
1650
2120
1050
Break
SESSION EIGHT: PANEL DISCUSSION: Are existing push and pull incentives sufficient to strengthen the antibiotic R&D pipeline and ensure treatments reach patients?
Chair: Professor Laura Piddock, GARDP - View Bio
1600
1700
2130
1100
Panel discussion
Dr Lesley Ann Ogilvie, Global AMR R&D Hub
Peter Beyer, GARDP - View Bio
James Anderson, GSK
1655
1755
2225
1155
Q&A
1705
1805
2235
1205
Closing remarks
Dr Christopher Longshaw, Shionogi BV & BSAC Honorary Treasurer - View Bio

Abstracts

Please read the instructions below carefully

Please submit your abstract(s) using the online submission form for consideration for ORAL and/or POSTER presentation at the conference.

Abstracts selected for oral presentation will be invited to present as part of Session Six on Day Two of the conference (5 minutes presentation each plus Q&A).

The deadline for ORAL abstract submission is 1700hrs GMT on Monday 13 November 2023
The deadline for POSTER abstract submission is 1700hrs GMT on Monday 13 November 2023

Please note our Conditions of Submission:

  • Abstracts must be submitted by the stated deadline, abstracts submitted after this time will not be considered.
  • The lead author should ideally be the presenting author. All correspondence will be sent to the lead author.
  • The presenting author must register for the conference.
  • Those submitting abstracts for ORAL presentation are also requested to submit a short video with a 2-minute elevator pitch of their professional background and overview of their research for the committee to review and make their final selection. Selected authors will be requested to pre-record their final presentation and to join Session Six to take part in the live Q&A discussion at the end of the session. Guidelines to oral presentations
  • If selected for POSTER presentation authors are required to submit their poster in pdf format prior to the conference.
  • All abstracts need to be submitted using the online submission form.

Deadlines for ORAL submissions:

Those submitting abstracts for ORAL presentation are requested to submit a short video with a 2-minute elevator pitch of their professional background and overview of their research for the committee to review and make their final selection. Oral submissions will not be considered without the 2-minute elevator pitch video.

Abstract and elevator pitch submission deadline: 1700hrs GMT on Monday 13 November 2023
Authors notified of final selection decision: Friday 8 December 2023
Author submission of final video: 1700hrs GMT on Tuesday 16 January 2024 (Files received after this time or not adhering to the stated requirements may not be included).

Deadlines for POSTER submissions:

Abstract submission deadline: 1700hrs GMT on Monday 13 November 2023
Authors notified of selection decision: Friday 8 December 2023
Author submission of final PDF poster: 1700hrs GMT on Tuesday 16 January 2024 (Files received after this time may not be included).

Structured Abstract (maximum word count 400 excluding graphs & tables):

  • an initial statement of specific objectives of the study, unless this is given in the title;
  • a brief statement of methods;
  • a summary of the results obtained;
  • specific conclusions.

For any queries regarding abstract submissions, please contact Esme Carruthers

Download Instructions
Click or drag a file to this area to upload.

Registration

Please register to attend this virtual conference free of charge using the link below.

If you have not already done so, you will need to create an account before you can register for this conference.

For any questions regarding registration, please contact Esme Carruthers.

For booking Terms and Conditions click here.

The conference is organised by GARDP and BSAC and independent of any industry sponsorship.